TIAA CREF Investment Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$8.92M Buy
282,945
+21,866
+8% +$637K 0.01% 1092
2018
Q4
$6.56M Buy
261,079
+1,709
+0.7% +$43.9K 0.01% 1197
2018
Q3
$7.48M Buy
259,370
+140,656
+118% +$2.63M ﹤0.01% 1298
2018
Q2
$1.45M Buy
+118,714
New +$1.36M ﹤0.01% 2326

Other funds holding CDNA

TIAA CREF Investment Management's CDNA Position: Q1 2019 in Review

TIAA CREF Investment Management increased its CareDx (CDNA) stake by 8.4% in Q1 2019, buying an estimated $637K and bringing the position to 282,945 shares worth $8.92M. The position accounts for 0.01% of the portfolio, ranked #1092.

TIAA CREF Investment Management first reported a position in CDNA in Q2 2018 and has held it in 4 quarters since. 182 funds tracked by Wall St. Rank hold CDNA as of Q1 2019.

  • TIAA CREF Investment Management held 282,945 shares of CareDx worth $8.92M as of Q1 2019.
  • TIAA CREF Investment Management bought 21,866 CareDx shares in Q1 2019, an estimated $637K.
  • CareDx made up 0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1092 holding.
  • TIAA CREF Investment Management first reported a position in CareDx in Q2 2018 and has held it in 4 quarters since.
  • 182 funds tracked by Wall St. Rank held CareDx as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.